產(chǎn)品詳情
中文名稱:烏苯美司 | 英文名稱:Ubenimex |
CAS:58970-76-6 | 有效期: 一年 |
產(chǎn)地: 陜西、西安 | 純度規(guī)格: ≥99% |
2018-07-24
烏苯美司
Ubenimex
RMB
1000
一年
陜西、西安
≥99%
English Name:Ubenimex
Test Method:HPLC
Purity:HPLC≥98%
[Synonyms]
Bestatin; [S-(R*,S*)]-N-(3-Amino-2-hydroxy-1-oxo-4-phenylbuty1)-L-leucine
[CAS No.]58970-76-6
[Mol. Formula]C16H24N2O4
[Mol. Weight]308.37
[Botanical Source]Streptomyces
[Loss on drying] ≤2.0%
[Catalogue No.]W-014
[Purity]>98% 99% by HPLC
[Packaging]20mg, 50mg,100mg,1g,10g,100g,kgs and so on
Package and quantity according to customer's detail requirement.
[Remark] In stock, customized for large scale.
關(guān)鍵字: Ubenimex;API;avtive pharmaceutical ingredients
公司簡(jiǎn)介
Xi’an Wanlong pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates. The company’s registered capital reaches CNY 75 million. The building area of company is over 2000000 square meters. All the work shops are compliant with GMP requirements.
There are more than 700 employees including over 70 RD staffs,20 experienced production management people and 8 senior professional registration specialists. Having a dynamic, high-quality team, which ensures our company sustainable and stable development.
We produce tablets, capsule, granules, injection and API, total 49 drug approval numbers and other intermediates. There are 4 API workshops, and two solid preparation plants, injection plants with GMP. Annual production capacity of 100 tons of raw material, solid dosage form annual output of 3 billion, injection annual output 1.3 billion bags. The drug products are widely used in the most
成立日期 |
1995-05-26
(30年)
|
注冊(cè)資本 |
7500.000000萬(wàn)
|
員工人數(shù) |
500人以上 |
年?duì)I業(yè)額 |
¥ 1億以上 |
主營(yíng)行業(yè) |
醫(yī)藥中間體,原料藥 |
經(jīng)營(yíng)模式 |
工廠 |